Showing posts with label Decrease the Incidence of Chemotherapy-Induced Myelosuppression. Show all posts
Showing posts with label Decrease the Incidence of Chemotherapy-Induced Myelosuppression. Show all posts
Tuesday, March 2, 2021

FDA Approves Cosela (trilaciclib) to Decrease the Incidence of Chemotherapy-Induced Myelosuppression

›
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, announced   the U.S. Food and Drug Administration (FDA)   approva...